|
NCCN Guidelines® Insights - Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020 |
1.00 |
04/10/2020 - 12:00am to 04/10/2021 - 12:00am |
|
NCCN Guidelines® Insights - Colorectal Cancer Screening, Version 2.2020 |
1.00 |
10/10/2020 - 12:00am to 10/10/2021 - 12:00am |
|
NCCN Guidelines® Insights - Cervical Cancer, Version 1.2020 |
1.00 |
06/10/2020 - 12:00am to 06/10/2021 - 12:00am |
|
NCCN Guidelines® Insights - Acute Myeloid Leukemia, Version 2.2021 |
1.00 |
01/10/2021 - 12:00am to 01/10/2022 - 12:00am |
|
Navigating the Jargon of Molecular Testing |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
|
Myeloproliferative Neoplasms: Emerging Treatment Options for Myelofibrosis |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
|
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Ovarian Cancer |
1.00 |
11/30/2020 - 12:00am to 03/14/2021 - 12:00am |
|
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Lung Cancer |
1.00 |
12/15/2020 - 12:00am to 05/23/2021 - 12:00am |
|
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Cutaneous T-Cell Lymphomas |
1.00 |
03/02/2021 - 12:00am to 07/25/2021 - 12:00am |
|
Management of Toxicities with Targeted Therapies for Breast Cancer |
0.25 |
03/15/2020 - 12:00am to 03/15/2021 - 12:00am |
|
Management of Rare Breast Cancers |
0.50 |
03/15/2020 - 12:00am to 03/15/2021 - 12:00am |
|
Management of Metastatic Breast Cancer, Including SABCS Updates |
0.75 |
03/15/2020 - 12:00am to 03/15/2021 - 12:00am |
|
Management of Cardiac Complications in Hematologic Malignancies |
0.75 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
|
Lymphoma 101: The Plot Thickens |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
|
Is There a Role for Proton Therapy in the Treatment of Breast Cancer? |
0.50 |
03/15/2020 - 12:00am to 03/15/2021 - 12:00am |
Facebook
Twitter
LinkedIn
Forward